Navera Investment Management Ltd. historic quarter change: Foreign Funds, Added
In funds and trusts that are not on this site's ETF list (sponsor series, commodity pools, money market) (depositary receipts and foreign shares traded over the counter), over 10 quarters from 2023-12-31 to 2026-06-30, Navera Investment Management Ltd. opened 0 positions, added to 0, reduced 0 and sold out of 0.
Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1842702), 10 quarters: Q2 2026 (2026-03-31 to 2026-06-30, filed 2026-08-11); Q1 2026 (2025-12-31 to 2026-03-31, filed 2026-05-12); Q4 2025 (2025-09-30 to 2025-12-31, filed 2026-02-12); Q3 2025 (2025-06-30 to 2025-09-30, filed 2025-10-29); Q2 2025 (2025-03-31 to 2025-06-30, filed 2025-07-23); Q1 2025 (2024-12-31 to 2025-03-31, filed 2025-05-12); Q4 2024 (2024-09-30 to 2024-12-31, filed 2025-01-31); Q3 2024 (2024-06-30 to 2024-09-30, filed 2024-10-18); Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-08-14); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-10). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2020-12-31.
No position of this class changed this way in the filings compared.
Similar Firms
| Firm Name | Country | 13F Value | Holdings |
|---|---|---|---|
| MONTANOVA CAPITAL, LLC | United States | $3.915B | 89 |
| Alesco Advisors, LLC, An ESL Co | United States | $3.919B | 243 |
| Donor Advised Charitable Giving, Inc. | United States | $3.922B | 32 |
| Channing Capital Management, LLC | United States | $3.905B | 108 |
| AMERICAN SECURITIES LLC | United States | $3.930B | 2 |
| MITSUI SUMITOMO INSURANCE CO LTD | Japan | $3.896B | 1 |
| Frazier Life Sciences Management, L.P. | United States | $3.887B | 38 |
| LOCUST WOOD CAPITAL ADVISERS, LLC | United States | $3.948B | 31 |
| Greenwoods Asset Management Hong Kong Ltd. | Hong Kong | $3.878B | 35 |
| TRIAN FUND MANAGEMENT, L.P. | United States | $3.860B | 9 |